Literature DB >> 16680590

Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome.

Brian Hung-Hin Lang1, Chung-Yau Lo, Wai-Fan Chan, Alfred King-Yin Lam, Koon-Yat Wan.   

Abstract

INTRODUCTION: The follicular variant of papillary thyroid carcinoma (FVPTC) is the most common histologic subtype of papillary thyroid carcinoma (PTC). However, it is still controversial whether FVPTC should behave differently from classical PTC (CPTC). The present study aimed at evaluating any potential difference in clinicopathologic features and long-term outcome of FVPTC as compared with CPTC. PATIENTS AND METHODS: Of 568 patients with PTC managed from 1973 to 2004, 308 were shown to have CPTC (54.2%) and 67 (11.8%) FVPTC after histologic review. The mean (+/- SD) follow-up period was 11.3 (+/- 8.9) years. The two groups were compared in terms of clinicopathological features, treatment received, and outcome regarding recurrence and disease-specific survival.
RESULTS: There was no difference in age and gender ratio between the CPTC and FVPTC patients. Both groups had similar tumor characteristics in terms of tumor size, presence of multifocality, capsular invasion, lymphovascular permeation, and perineural infiltration. However, FVPTC patients had significantly fewer histologically confirmed cervical lymph node metastases (P = 0.027) and extrathyroidal involvement (P = 0.005). The proportion of bilateral resection, adjuvant radioactive iodine, and lymph node dissection did not differ significantly between the two groups. The FVPTC patients had a more favorable tumor risk by DeGroot classification (P = 0.003) and MACIS (Metastasis, Age, Completeness of excision, Invasiveness, and Size) score (P = 0.026). The 10- and 15-year actuarial disease-specific survivals did not differ significantly between FVPTC and CPTC patients (96.2% versus 90.7% and 96.2% versus 89.1%, respectively).
CONCLUSIONS: Although patients with FVPTC had more favorable clinicopathologic features and a better tumor risk group profile, their long-term outcome was similar to that of CPTC patients.

Entities:  

Mesh:

Year:  2006        PMID: 16680590     DOI: 10.1007/s00268-005-0356-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

Review 1.  Follicular-patterned lesions of the thyroid: the bane of the pathologist.

Authors:  Zubair W Baloch; Virginia A Livolsi
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

2.  High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma.

Authors:  Chung-Yau Lo; Kin-Yin Lam; Pauline P Leung; John M Luk
Journal:  Eur J Endocrinol       Date:  2005-04       Impact factor: 6.664

3.  Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma.

Authors:  Laura Falvo; Antonio Catania; Vito D'Andrea; Antonella Marzullo; Maria Cristina Giustiniani; Enrico De Antoni
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

4.  Papillary thyroid carcinoma: prognostic index for survival including the histological variety.

Authors:  S O Sebastian; J M Gonzalez; P P Paricio; J S Perez; D P Flores; A P Madrona; P R Romero; F J Tebar
Journal:  Arch Surg       Date:  2000-03

5.  Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.

Authors:  Jamal Zidan; Drumea Karen; Moshe Stein; Edward Rosenblatt; Walid Basher; Abraham Kuten
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

6.  Follicular variant of papillary thyroid carcinoma. A clinicopathologic study.

Authors:  E T Tielens; S I Sherman; R H Hruban; P W Ladenson
Journal:  Cancer       Date:  1994-01-15       Impact factor: 6.860

7.  Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.

Authors:  Zhaowen Zhu; Manoj Gandhi; Marina N Nikiforova; Andrew H Fischer; Yuri E Nikiforov
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

8.  Follicular variant of papillary thyroid carcinoma: a long-term follow-up.

Authors:  Christian Passler; Gerhard Prager; Christian Scheuba; Barbara E Niederle; Klaus Kaserer; Georg Zettinig; Bruno Niederle
Journal:  Arch Surg       Date:  2003-12

9.  Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma.

Authors:  Ricardo V Lloyd; Lori A Erickson; Mary B Casey; King Y Lam; Christine M Lohse; Sylvia L Asa; John K C Chan; Ronald A DeLellis; H Ruben Harach; Kennichi Kakudo; Virginia A LiVolsi; Juan Rosai; Thomas J Sebo; Manuel Sobrinho-Simoes; Bruce M Wenig; Marick E Lae
Journal:  Am J Surg Pathol       Date:  2004-10       Impact factor: 6.394

10.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

View more
  38 in total

1.  Classical and follicular variant papillary thyroid carcinoma: comparison of clinical, ultrasonographical, cytological, and histopathological features in 444 patients.

Authors:  Didem Ozdemir; Reyhan Ersoy; Neslihan Cuhaci; Dilek Arpaci; Eren P Ersoy; Birol Korukluoglu; Gulnur Guler; Bekir Cakir
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

2.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

3.  Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis.

Authors:  Jing Yang; Yanping Gong; Shuping Yan; Qingquan Shi; Jingqiang Zhu; Zhihui Li; Qiang Chen; Rixiang Gong
Journal:  Mol Clin Oncol       Date:  2015-04-06

4.  Sonographic differences between conventional and follicular variant papillary thyroid carcinoma.

Authors:  Nicola M Hughes; Andreea Nae; Josephine Barry; Brendan Fitzgerald; Linda Feeley; Patrick Sheahan
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-10       Impact factor: 2.503

5.  Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.

Authors:  Marco Raffaelli; Carmela De Crea; Luca Sessa; Guido Fadda; Celestino Pio Lombardi; Rocco Bellantone
Journal:  Endocrine       Date:  2018-05-16       Impact factor: 3.633

6.  Can New Ultrasound Signs Help in Identifying Follicular Variant of Papillary Carcinoma of Thyroid? - A Pilot Study.

Authors:  C Anuradha; M T Manipadam; H S Asha; N Dukhabandhu; D Abraham; M J Paul
Journal:  Ultrasound Int Open       Date:  2016-04-28

7.  BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.

Authors:  Carol Li; Kathleen C Lee; Eric B Schneider; Martha A Zeiger
Journal:  J Clin Endocrinol Metab       Date:  2012-10-09       Impact factor: 5.958

8.  Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.

Authors:  Jarosław Jendrzejewski; Sandya Liyanarachchi; Andrew Eiterman; Andrew Thomas; Huiling He; Rebecca Nagy; Leigha Senter; Krzysztof Sworczak; Albert de la Chapelle
Journal:  Int J Cancer       Date:  2018-12-03       Impact factor: 7.396

9.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

10.  Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.

Authors:  Xiao-Min Yu; David F Schneider; Glen Leverson; Herbert Chen; Rebecca S Sippel
Journal:  Thyroid       Date:  2013-09-11       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.